Astellas Receives Approval for XTANDI Tablets, a Treatment for Castration-Resistant Prostate Cancer, in Japan
Astellas Pharma Inc. announced that 40 mg XTANDI Tablets and 80 mg XTANDI Tablets received manufacturing and marketing approval in...
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending...
Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market
There's a new tech partnership in diabetes, this time between Eli Lilly and Livongo. And it's looking to tap real-world...
Chinese researchers report first lung stem cell transplantation clinical trial
A research team from Tongji University in China have made a breakthrough in human lung regeneration technology. For the first...
Using injectable self-assembled nanomaterials for sustained delivery of drugs Drug
Because they can be programmed to travel the body and selectively target cancer and other sites of disease, nanometer-scale vehicles...
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease
Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and...
Old antibiotic compounds could become life-saving drugs
Turns out, discarded antibiotic compounds could be developed for new life-saving drugs.In the heyday of antibiotic development in the mid-20th...
FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Allergan plc , a leading global pharmaceutical company, announced that the U.S. FDA has approved Allergan's supplemental New Drug Application...
Sanofi, DNDi Seek EMA Review For Sleeping Sickness Drug
The Paris, France-based drugmaker said it is hoped that the treatment will contribute to the elimination of the disease. The...
Nasal Spray Could Lower Risk Of Opioid Addiction
The animal study tested whether using nanotechnology enables the exclusive delivery of the drug into the brain and causes analgesia...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.